Edition:
United Kingdom

People: Regeneron Pharmaceuticals Inc (REGN.OQ)

REGN.OQ on NASDAQ Stock Exchange Global Select Market

374.21USD
18 Jan 2018
Change (% chg)

$0.14 (+0.04%)
Prev Close
$374.07
Open
$374.21
Day's High
$374.21
Day's Low
$374.21
Volume
4,497
Avg. Vol
292,227
52-wk High
$543.50
52-wk Low
$340.13

Van Plew, Daniel 

Mr. Daniel P. Van Plew is Executive Vice President, General Manager - Industrial Operations and Product Supply of the Company. Mr. Van Plew served as Senior Vice President and General Manager, Industrial Operations and Product Supply. Prior to that date, he served as Vice President and General Manager, Industrial Operations and Product Supply since joining the Company in 2007. From 2006 until 2007, Mr. Van Plew served as Executive Vice President, R&D and Technical Operations of Crucell Holland B.V., a global biopharmaceutical company. Between 2004 and 2006, Mr. Van Plew held positions of increasing responsibility at Chiron Biopharmaceuticals, part of Chiron Corporation, a biotechnology company, most recently as Senior Director, Vacaville Operations. From 1998 until 2004, Mr. Van Plew held various managerial positions in the health and life sciences practice at Accenture, Ltd., a management consulting business. Mr. Van Plew received his M.S. in Chemistry from The Pennsylvania State University and his M.B.A. from Michigan State University.

Basic Compensation

Total Annual Compensation, USD 632,052
Restricted Stock Award, USD --
Long-Term Incentive Plans, USD --
All Other, USD 1,556,940
Fiscal Year Total, USD 2,188,990

Options Compensation

  Quantity Market Value
Exercisable -- --
Unexercisable -- --
Exercised 25,000 277,500.00
Name Fiscal Year Total

P. Roy Vagelos

13,240,600

Leonard Schleifer

28,337,500

Robert Landry

5,164,730

Daniel Van Plew

2,188,990

Neil Stahl

10,985,400

Joseph LaRosa

--
As Of  31 Dec 2016